These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9241417)

  • 1. Structural perspectives of phospholamban, a helical transmembrane pentamer.
    Arkin IT; Adams PD; Brünger AT; Smith SO; Engelman DM
    Annu Rev Biophys Biomol Struct; 1997; 26():157-79. PubMed ID: 9241417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural model of the phospholamban ion channel complex in phospholipid membranes.
    Arkin IT; Rothman M; Ludlam CF; Aimoto S; Engelman DM; Rothschild KJ; Smith SO
    J Mol Biol; 1995 May; 248(4):824-34. PubMed ID: 7752243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical structure of phospholamban in membrane bilayers.
    Smith SO; Kawakami T; Liu W; Ziliox M; Aimoto S
    J Mol Biol; 2001 Nov; 313(5):1139-48. PubMed ID: 11700069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for the transmembrane region of the phospholamban pentamer: which is correct?
    Adams PD; Lee AS; Brünger AT; Engelman DM
    Ann N Y Acad Sci; 1998 Sep; 853():178-85. PubMed ID: 10603945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation by cAMP-dependent protein kinase modulates the structural coupling between the transmembrane and cytosolic domains of phospholamban.
    Li J; Bigelow DJ; Squier TC
    Biochemistry; 2003 Sep; 42(36):10674-82. PubMed ID: 12962492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
    Pollesello P; Annila A; Ovaska M
    Biophys J; 1999 Apr; 76(4):1784-95. PubMed ID: 10096878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis and functional properties of the membrane-intrinsic protein phospholamban.
    Vorherr T; Wrzosek A; Chiesi M; Carafoli E
    Protein Sci; 1993 Mar; 2(3):339-47. PubMed ID: 8384040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural constraints on the transmembrane and juxtamembrane regions of the phospholamban pentamer in membrane bilayers: Gln29 and Leu52.
    Liu W; Fei JZ; Kawakami T; Smith SO
    Biochim Biophys Acta; 2007 Dec; 1768(12):2971-8. PubMed ID: 17996192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure of a water-soluble analog of the membrane protein phospholamban: sequence determinants defining the topology of tetrameric and pentameric coiled coils.
    Slovic AM; Stayrook SE; North B; Degrado WF
    J Mol Biol; 2005 May; 348(3):777-87. PubMed ID: 15826670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secondary structure of phospholamban: a two-dimensional NMR study.
    Maslennikov IV; Sobol AG; Anagli J; James P; Vorherr T; Arseniev AS; Carafoli E
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1200-7. PubMed ID: 8554577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fourier transform infrared spectroscopy and site-directed isotope labeling as a probe of local secondary structure in the transmembrane domain of phospholamban.
    Ludlam CF; Arkin IT; Liu XM; Rothman MS; Rath P; Aimoto S; Smith SO; Engelman DM; Rothschild KJ
    Biophys J; 1996 Apr; 70(4):1728-36. PubMed ID: 8785331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural changes in the cytoplasmic domain of phospholamban by phosphorylation at Ser16: a molecular dynamics study.
    Sugita Y; Miyashita N; Yoda T; Ikeguchi M; Toyoshima C
    Biochemistry; 2006 Oct; 45(39):11752-61. PubMed ID: 17002276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition.
    Li J; Bigelow DJ; Squier TC
    Biochemistry; 2004 Apr; 43(13):3870-9. PubMed ID: 15049694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
    Coll KE; Johnson RG; McKenna E
    Biochemistry; 1999 Feb; 38(8):2444-51. PubMed ID: 10029538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.
    Tilgmann C; Pollesello P; Ovaska M; Kaivola J; Pystynen J; Tiainen E; Yliperttula M; Annila A; Levijoki J
    Chem Biol Drug Des; 2013 Apr; 81(4):463-73. PubMed ID: 22578098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.
    Toyoshima C; Asahi M; Sugita Y; Khanna R; Tsuda T; MacLennan DH
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):467-72. PubMed ID: 12525698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural organization of the pentameric transmembrane alpha-helices of phospholamban, a cardiac ion channel.
    Arkin IT; Adams PD; MacKenzie KR; Lemmon MA; Brünger AT; Engelman DM
    EMBO J; 1994 Oct; 13(20):4757-64. PubMed ID: 7525269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic studies of phospholamban variants in phospholipid bilayers.
    Clayton JC; Hughes E; Middleton DA
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):913-5. PubMed ID: 16246009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structural model of the complex formed by phospholamban and the calcium pump of sarcoplasmic reticulum obtained by molecular mechanics.
    Hutter MC; Krebs J; Meiler J; Griesinger C; Carafoli E; Helms V
    Chembiochem; 2002 Dec; 3(12):1200-8. PubMed ID: 12465028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of helical membrane protein topology using residual dipolar couplings and exhaustive search algorithm: application to phospholamban.
    Mascioni A; Eggimann BL; Veglia G
    Chem Phys Lipids; 2004 Nov; 132(1):133-44. PubMed ID: 15530454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.